PDB Short entry for 2XK7 HEADER TRANSFERASE 07-JUL-10 2XK7 TITLE STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 23 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE NEK2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 1-271; COMPND 5 SYNONYM: NEK2, NEVER IN MITOSIS A-RELATED KINASE 2, NIMA-RELATED COMPND 6 PROTEIN KINASE 2, NIMA-LIKE PROTEIN KINASE 1, HSPK 21; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSFERASE, CENTROSOME, MITOSIS EXPDTA X-RAY DIFFRACTION AUTHOR C.MAS-DROUX,R.BAYLISS REVDAT 4 20-DEC-23 2XK7 1 REMARK REVDAT 3 25-MAY-11 2XK7 1 JRNL REMARK REVDAT 2 03-NOV-10 2XK7 1 TITLE REMARK REVDAT 1 27-OCT-10 2XK7 0 JRNL AUTH D.K.WHELLIGAN,S.SOLANKI,D.TAYLOR,D.W.THOMSON,K.M.CHEUNG, JRNL AUTH 2 K.BOXALL,C.MAS-DROUX,C.BARILLARI,S.BURNS,C.G.GRUMMITT, JRNL AUTH 3 I.COLLINS,R.L.VAN MONTFORT,G.W.AHERNE,R.BAYLISS,S.HOELDER JRNL TITL AMINOPYRAZINE INHIBITORS BINDING TO AN UNUSUAL INACTIVE JRNL TITL 2 CONFORMATION OF THE MITOTIC KINASE NEK2: SAR AND STRUCTURAL JRNL TITL 3 CHARACTERIZATION. JRNL REF J.MED.CHEM. V. 53 7682 2010 JRNL REFN ISSN 0022-2623 JRNL PMID 20936789 JRNL DOI 10.1021/JM1008727 REMARK 2 REMARK 2 RESOLUTION. 1.99 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.99 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.64 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.010 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.8 REMARK 3 NUMBER OF REFLECTIONS : 21970 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.177 REMARK 3 R VALUE (WORKING SET) : 0.175 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1074 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 36.6420 - 3.9826 0.98 2774 132 0.1898 0.2517 REMARK 3 2 3.9826 - 3.1616 0.99 2731 131 0.1457 0.1876 REMARK 3 3 3.1616 - 2.7621 0.99 2671 137 0.1585 0.2044 REMARK 3 4 2.7621 - 2.5097 0.97 2643 138 0.1619 0.2233 REMARK 3 5 2.5097 - 2.3298 0.97 2633 140 0.1596 0.1942 REMARK 3 6 2.3298 - 2.1925 0.95 2552 142 0.1705 0.2529 REMARK 3 7 2.1925 - 2.0827 0.92 2495 119 0.1961 0.2469 REMARK 3 8 2.0827 - 1.9920 0.89 2397 135 0.2229 0.2562 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.33 REMARK 3 B_SOL : 60.77 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.250 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.320 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 24.96 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.05750 REMARK 3 B22 (A**2) : -5.94140 REMARK 3 B33 (A**2) : 5.88390 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 6.67800 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2072 REMARK 3 ANGLE : 0.977 2796 REMARK 3 CHIRALITY : 0.069 303 REMARK 3 PLANARITY : 0.009 352 REMARK 3 DIHEDRAL : 19.275 783 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: (CHAIN A AND RESID 3:63) REMARK 3 ORIGIN FOR THE GROUP (A): -29.4163 28.6878 -9.9926 REMARK 3 T TENSOR REMARK 3 T11: 0.1962 T22: 0.3451 REMARK 3 T33: 0.3396 T12: 0.0218 REMARK 3 T13: 0.0501 T23: -0.1105 REMARK 3 L TENSOR REMARK 3 L11: 1.9304 L22: 1.4137 REMARK 3 L33: 1.9291 L12: 0.3205 REMARK 3 L13: -1.3956 L23: 0.8842 REMARK 3 S TENSOR REMARK 3 S11: -0.0244 S12: -0.6077 S13: 0.5659 REMARK 3 S21: 0.1556 S22: 0.0999 S23: 0.3398 REMARK 3 S31: 0.0188 S32: 0.1116 S33: -0.0373 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: (CHAIN A AND RESID 64:157) REMARK 3 ORIGIN FOR THE GROUP (A): -18.1442 21.1291 -19.8897 REMARK 3 T TENSOR REMARK 3 T11: 0.1417 T22: 0.1500 REMARK 3 T33: 0.1675 T12: 0.0278 REMARK 3 T13: 0.0179 T23: -0.0111 REMARK 3 L TENSOR REMARK 3 L11: 1.5250 L22: 0.9960 REMARK 3 L33: 0.3167 L12: -0.9570 REMARK 3 L13: -0.1724 L23: 0.0336 REMARK 3 S TENSOR REMARK 3 S11: -0.1021 S12: -0.0582 S13: -0.0459 REMARK 3 S21: 0.0395 S22: 0.0294 S23: 0.1341 REMARK 3 S31: -0.0382 S32: -0.1013 S33: 0.0616 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: (CHAIN A AND RESID 158:279) REMARK 3 ORIGIN FOR THE GROUP (A): -5.7558 7.9480 -19.7849 REMARK 3 T TENSOR REMARK 3 T11: 0.1100 T22: 0.0818 REMARK 3 T33: 0.0860 T12: 0.0115 REMARK 3 T13: 0.0031 T23: 0.0033 REMARK 3 L TENSOR REMARK 3 L11: 0.7226 L22: 1.6787 REMARK 3 L33: 0.9965 L12: -0.6949 REMARK 3 L13: 0.0719 L23: 0.3064 REMARK 3 S TENSOR REMARK 3 S11: -0.1380 S12: -0.1167 S13: 0.0016 REMARK 3 S21: 0.0836 S22: 0.0621 S23: -0.0935 REMARK 3 S31: 0.1266 S32: -0.0463 S33: 0.0788 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: (CHAIN B AND RESID 1) REMARK 3 ORIGIN FOR THE GROUP (A): -25.7970 20.5845 -18.5876 REMARK 3 T TENSOR REMARK 3 T11: 0.3096 T22: 0.2459 REMARK 3 T33: 0.4249 T12: 0.0733 REMARK 3 T13: -0.0311 T23: -0.0123 REMARK 3 L TENSOR REMARK 3 L11: 3.2139 L22: 4.8932 REMARK 3 L33: 4.8831 L12: 0.1484 REMARK 3 L13: 3.1715 L23: 2.4673 REMARK 3 S TENSOR REMARK 3 S11: 0.3291 S12: 0.1020 S13: -0.4989 REMARK 3 S21: 0.4662 S22: 0.3883 S23: -0.0455 REMARK 3 S31: 0.2402 S32: 0.0560 S33: -0.4527 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2XK7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-JUL-10. REMARK 100 THE DEPOSITION ID IS D_1290044543. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9763 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22841 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.990 REMARK 200 RESOLUTION RANGE LOW (A) : 50.370 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 6.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.06900 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.99 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.10 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.37400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2WQO REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.37 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.58 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 50.60000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.38500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 50.60000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 28.38500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 PRO A 2 REMARK 465 GLY A 17 REMARK 465 SER A 18 REMARK 465 TYR A 19 REMARK 465 ASP A 132 REMARK 465 GLY A 133 REMARK 465 GLY A 134 REMARK 465 HIS A 135 REMARK 465 THR A 136 REMARK 465 VAL A 137 REMARK 465 LEU A 138 REMARK 465 HIS A 139 REMARK 465 PHE A 160 REMARK 465 GLY A 161 REMARK 465 LEU A 162 REMARK 465 ALA A 163 REMARK 465 ARG A 164 REMARK 465 ILE A 165 REMARK 465 LEU A 166 REMARK 465 ASN A 167 REMARK 465 HIS A 168 REMARK 465 ASP A 169 REMARK 465 THR A 170 REMARK 465 SER A 171 REMARK 465 PHE A 172 REMARK 465 ALA A 173 REMARK 465 LYS A 174 REMARK 465 THR A 175 REMARK 465 ARG A 190 REMARK 465 MET A 191 REMARK 465 SER A 192 REMARK 465 TYR A 193 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 4 CG CD NE CZ NH1 NH2 REMARK 470 THR A 16 OG1 CG2 REMARK 470 LEU A 58 CG CD1 CD2 REMARK 470 ARG A 60 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 61 CG CD OE1 OE2 REMARK 470 ARG A 73 NE CZ NH1 NH2 REMARK 470 ARG A 77 CG CD NE CZ NH1 NH2 REMARK 470 ASN A 79 CG OD1 ND2 REMARK 470 ARG A 105 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 130 CD NE CZ NH1 NH2 REMARK 470 GLN A 187 CG CD OE1 NE2 REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2036 DISTANCE = 6.57 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 30E A 1280 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 1282 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 1283 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 1284 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 1285 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2W5B RELATED DB: PDB REMARK 900 HUMAN NEK2 KINASE ATPGAMMAS-BOUND REMARK 900 RELATED ID: 2XKC RELATED DB: PDB REMARK 900 STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 14 REMARK 900 RELATED ID: 2XNP RELATED DB: PDB REMARK 900 STRUCTURE OF NEK2 BOUND TO CCT244858 REMARK 900 RELATED ID: 2WQO RELATED DB: PDB REMARK 900 STRUCTURE OF NEK2 BOUND TO THE AMINOPYRIDINE CCT241950 REMARK 900 RELATED ID: 2JAV RELATED DB: PDB REMARK 900 HUMAN KINASE WITH PYRROLE-INDOLINONE LIGAND REMARK 900 RELATED ID: 2XKE RELATED DB: PDB REMARK 900 STRUCTURE OF NEK2 BOUND TO AMINIPYRAZINE COMPOUND 5 REMARK 900 RELATED ID: 2W5H RELATED DB: PDB REMARK 900 HUMAN NEK2 KINASE APO REMARK 900 RELATED ID: 2XKD RELATED DB: PDB REMARK 900 STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 12 REMARK 900 RELATED ID: 2XKF RELATED DB: PDB REMARK 900 STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 2 REMARK 900 RELATED ID: 2XK8 RELATED DB: PDB REMARK 900 STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 15 REMARK 900 RELATED ID: 2XNO RELATED DB: PDB REMARK 900 STRUCTURE OF NEK2 BOUND TO CCT243779 REMARK 900 RELATED ID: 2XK6 RELATED DB: PDB REMARK 900 STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 36 REMARK 900 RELATED ID: 2XNN RELATED DB: PDB REMARK 900 STRUCTURE OF NEK2 BOUND TO CCT242430 REMARK 900 RELATED ID: 2XK4 RELATED DB: PDB REMARK 900 STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 17 REMARK 900 RELATED ID: 2XK3 RELATED DB: PDB REMARK 900 STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 35 REMARK 900 RELATED ID: 2XNM RELATED DB: PDB REMARK 900 STRUCTURE OF NEK2 BOUND TO CCT REMARK 900 RELATED ID: 2W5A RELATED DB: PDB REMARK 900 HUMAN NEK2 KINASE ADP-BOUND DBREF 2XK7 A 1 271 UNP P51955 NEK2_HUMAN 1 271 SEQADV 2XK7 LEU A 272 UNP P51955 EXPRESSION TAG SEQADV 2XK7 GLU A 273 UNP P51955 EXPRESSION TAG SEQADV 2XK7 HIS A 274 UNP P51955 EXPRESSION TAG SEQADV 2XK7 HIS A 275 UNP P51955 EXPRESSION TAG SEQADV 2XK7 HIS A 276 UNP P51955 EXPRESSION TAG SEQADV 2XK7 HIS A 277 UNP P51955 EXPRESSION TAG SEQADV 2XK7 HIS A 278 UNP P51955 EXPRESSION TAG SEQADV 2XK7 HIS A 279 UNP P51955 EXPRESSION TAG SEQRES 1 A 279 MET PRO SER ARG ALA GLU ASP TYR GLU VAL LEU TYR THR SEQRES 2 A 279 ILE GLY THR GLY SER TYR GLY ARG CYS GLN LYS ILE ARG SEQRES 3 A 279 ARG LYS SER ASP GLY LYS ILE LEU VAL TRP LYS GLU LEU SEQRES 4 A 279 ASP TYR GLY SER MET THR GLU ALA GLU LYS GLN MET LEU SEQRES 5 A 279 VAL SER GLU VAL ASN LEU LEU ARG GLU LEU LYS HIS PRO SEQRES 6 A 279 ASN ILE VAL ARG TYR TYR ASP ARG ILE ILE ASP ARG THR SEQRES 7 A 279 ASN THR THR LEU TYR ILE VAL MET GLU TYR CYS GLU GLY SEQRES 8 A 279 GLY ASP LEU ALA SER VAL ILE THR LYS GLY THR LYS GLU SEQRES 9 A 279 ARG GLN TYR LEU ASP GLU GLU PHE VAL LEU ARG VAL MET SEQRES 10 A 279 THR GLN LEU THR LEU ALA LEU LYS GLU CYS HIS ARG ARG SEQRES 11 A 279 SER ASP GLY GLY HIS THR VAL LEU HIS ARG ASP LEU LYS SEQRES 12 A 279 PRO ALA ASN VAL PHE LEU ASP GLY LYS GLN ASN VAL LYS SEQRES 13 A 279 LEU GLY ASP PHE GLY LEU ALA ARG ILE LEU ASN HIS ASP SEQRES 14 A 279 THR SER PHE ALA LYS THR PHE VAL GLY THR PRO TYR TYR SEQRES 15 A 279 MET SER PRO GLU GLN MET ASN ARG MET SER TYR ASN GLU SEQRES 16 A 279 LYS SER ASP ILE TRP SER LEU GLY CYS LEU LEU TYR GLU SEQRES 17 A 279 LEU CYS ALA LEU MET PRO PRO PHE THR ALA PHE SER GLN SEQRES 18 A 279 LYS GLU LEU ALA GLY LYS ILE ARG GLU GLY LYS PHE ARG SEQRES 19 A 279 ARG ILE PRO TYR ARG TYR SER ASP GLU LEU ASN GLU ILE SEQRES 20 A 279 ILE THR ARG MET LEU ASN LEU LYS ASP TYR HIS ARG PRO SEQRES 21 A 279 SER VAL GLU GLU ILE LEU GLU ASN PRO LEU ILE LEU GLU SEQRES 22 A 279 HIS HIS HIS HIS HIS HIS HET 30E A1280 30 HET CL A1281 1 HET CL A1282 1 HET CL A1283 1 HET CL A1284 1 HET CL A1285 1 HET CL A1286 1 HETNAM 30E (3R,4R)-1-[3-AMINO-6-(3,4,5-TRIMETHOXYPHENYL)PYRAZIN-2- HETNAM 2 30E YL]-3-ETHYLPIPERIDINE-4-CARBOXYLIC ACID HETNAM CL CHLORIDE ION FORMUL 2 30E C21 H28 N4 O5 FORMUL 3 CL 6(CL 1-) FORMUL 9 HOH *189(H2 O) HELIX 1 1 ARG A 4 GLU A 6 5 3 HELIX 2 2 THR A 45 LEU A 62 1 18 HELIX 3 3 LEU A 94 GLU A 104 1 11 HELIX 4 4 ASP A 109 SER A 131 1 23 HELIX 5 5 LYS A 143 ALA A 145 5 3 HELIX 6 6 ASN A 194 LEU A 212 1 19 HELIX 7 7 SER A 220 GLY A 231 1 12 HELIX 8 8 SER A 241 LEU A 252 1 12 HELIX 9 9 LYS A 255 ARG A 259 5 5 HELIX 10 10 SER A 261 GLU A 267 1 7 HELIX 11 11 LEU A 272 HIS A 276 5 5 SHEET 1 AA 5 TYR A 8 GLY A 15 0 SHEET 2 AA 5 ARG A 21 ARG A 27 -1 O CYS A 22 N ILE A 14 SHEET 3 AA 5 ILE A 33 ASP A 40 -1 O LEU A 34 N ILE A 25 SHEET 4 AA 5 THR A 81 GLU A 87 -1 O LEU A 82 N LEU A 39 SHEET 5 AA 5 TYR A 70 ASP A 76 -1 N TYR A 71 O VAL A 85 SHEET 1 AB 3 GLY A 92 ASP A 93 0 SHEET 2 AB 3 VAL A 147 LEU A 149 -1 N LEU A 149 O GLY A 92 SHEET 3 AB 3 VAL A 155 LEU A 157 -1 O LYS A 156 N PHE A 148 SITE 1 AC1 12 CYS A 22 VAL A 35 TYR A 70 MET A 86 SITE 2 AC1 12 GLU A 87 TYR A 88 CYS A 89 GLU A 90 SITE 3 AC1 12 GLY A 92 ASP A 93 SER A 96 ASP A 159 SITE 1 AC2 2 GLU A 110 ARG A 239 SITE 1 AC3 4 ASN A 154 HIS A 277 HIS A 279 HOH A2107 SITE 1 AC4 4 SER A 261 VAL A 262 HOH A2067 HOH A2093 SITE 1 AC5 2 ARG A 235 HOH A2066 CRYST1 101.200 56.770 74.140 90.00 127.61 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009881 0.000000 0.007612 0.00000 SCALE2 0.000000 0.017615 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017026 0.00000